(1)
HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE–RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES. ITFTTDM 2026, 4 (2), 299-308.